John G. Saia - 01 Jun 2025 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Chief Legal Officer
Signature
/s/ John G. Saia
Issuer symbol
GH
Transactions as of
01 Jun 2025
Transactions value $
-$5,606
Form type
4
Filing time
02 Jun 2025, 18:05:44 UTC
Previous filing
16 Apr 2025
Next filing
16 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Saia John G. Chief Legal Officer 3100 HANOVER STREET, PALO ALTO /s/ John G. Saia 02 Jun 2025 0001737840

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Options Exercise $0 +263 +0.61% $0.00 43.2K 01 Jun 2025 Direct
transaction GH Common Stock Tax liability -$5.61K -138 -0.32% $40.62 43.1K 01 Jun 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Restricted Stock Units Options Exercise $0 -263 -49.91% $0.00 264 01 Jun 2025 Common Stock 263 $0.00 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2 The restricted stock unit award was granted on November 2, 2021, and vested as to 25% of the shares subject to such award on September 1, 2022. The remaining 75% of the shares subject to such award vests in equal installments on each quarterly anniversary of September 1, 2022 during the three-year period thereafter.
F3 Not applicable for Restricted Stock Units.